Materials:P3X63Ag8.653murinemyelomaorYB2/0(maintainedat<1x106/ml)50%w/vPEG1500,warmedto37°C Medium:IMDMsupplementedwith20%fetalbovineserum,4mML-glutamine,1mMsodiumpyruvate,50Upenicillin,50µgstreptomycinand50µM2-MEintheabsenceorpresenceofHATorHTforselection(I-20). Procedure: NOTE:Allwashesareat1,000rpmfor10minutesat4°Cusingserumfreemedia TissueCollection:1.SacrificeanimalbyCO2inhalation.2.Removeperitonealcellsfromnaivemouseforuseasfeedercellsbyperitoneallavage.PlacecellsonICE.3.Sacrificeimmuneanimalandremovespleen.PlaceonICE. CellPreparation:1.Teasespleeninicecoldserum-freemedium(I-0).PasscellsUSPensionthroughaFalcon70microncellfilterandsuspendin50mloficecoldI-0.Centrifugeandwashcellsthreetimesat4°CinI-0.Resuspendcellsafterthethirdwashin10mlI-0andcountviablecells.Keepcellsonice.2.Concurrentlywiththespleenocytes,centrifugeandwashmyelomacellsthreetimes,usingI-0andresuspendinI-0.Countviablecells.3.Inaddition,washperitonealcellsinI-0twice,resuspendinI-20andcount.4.Addanappropriatenumberofmyelomacellstotheentirevolumeofspleencellsaccordingtothefollowingratiosandcentrifugetogether. FusionProtocol:1.Aspirateallsupernatantandsuspendpelletbytappingtheendofthetube.Placetubeincontainerofwarmwater(37°C).Gradually,overaperiodof30seconds,add1mlof37°CPEGwhiletappingthesidefothetubetoachievethoroughmixing.Overthenext90secondscontinuetomix.Afterapproximately1minute40secondsstopmixingandfilla5mlpipetwithwarmI-0.Whenexactly2minuteshaveelasped,dilutethePEG/cellmixtureslowlybyaddingdropwise1mlofI-0overa1minutetimespan.Duringthenext1minute,add2mlI-0dropwise.Theremaining2mlI-0inthepipetisaddedduringthenext40seconds.Nextusea10mlpipetandadd14ml37°CI-0duringthelast1minuteperiod.Bringthetotalvolumeto50mlusingI-20.Centrifugeat4°CandresuspendinHATmediumattheappropriatevolumetobringthecellstothefollowingconcentrations: Alternatively,thecellscanberesuspendedinI-20+2-MEwith150µladdedperwell.Anadditional50µlofa4XHATsolutioncanbeaddedat16-24hoursafterfusion. 2.Addperitonealcellstothefusedcellsat2.5x104cellsperml(thiswillresultinaplatingof5x103PECperwell). 3.Dispensecellsinto96wellplatesasfollows:CellsinI-20+2-ME150µlperwell+50µlperwell4XHATafter18-24hrs FeedingSchedule: Thedayofthefusionisconsideredday0.Fusionplatesareexaminedat24-48hoursforanyabnormalities(i.e.bacterialcontamination).Onday7,wellsareinspectedvisuallyandthenfed.Onehalfofthevolumeineachwellisaspiratedusingasterilepasteurpipet.Anewpipetisusedforeachplate.Wellsarefedwith125µlofI-20+2ME+HATondays7,11andthereafterasneeded,i.e.Mon.,Wed.,Fri. Culturesareexaminedvisuallyateachfeeding.Onceamajorityofwellsappear50%confluentforgrowth,supernatantsareharvestedforscreeningbytheinvestigator.Platesarefedatthistime. **Investigatorsshouldprovideinformationontheserumtiteroftheimmunizedanimal.Ifthetiterisgreaterthan1:10,000,itmaybeimportanttofeedtheculturesatleast3-4timespriortothescreening.Thiswillessentially\"washaway\"anyantibodyreleasefromdyingBcellsanddecreasebackgroundIglevels. References Kohler,G.andC.Milstein.1975.Continuousculturesoffusedcellssecretingantibodyofpredefinedspecificity.Nature256:495. Sanchez-Madrid,F.,P.SzklutandT.A.Springer.1983.Stablehamster-mousehybridomasproducingIgGandIgMhamstermonoclonalantibodiesofdefinedspecificity.J.Immunol.130:309. Sheehan,K.C.F.,J.CalderonandR.D.Schreiber.1988.GenerationandcharacterizationofmonoclonalantibodiesspecificforthehumanIFNgammareceptor.J.Immunol.140:4231. Sheehan,K.C.F.,N.H.RuddleandR.D.Schreiber.1989.GenerationandcharacterizationofhamstermonoclonalantibodiesthatneutralizemurineTumorNecrosisFactors.J.Immunol.142:3884.Species Spleenocytes:Myeloma mouse-mouse 5:1 hamster-mouse 4:1 rat-mouse 5:1 Tcellfusion 1:1 Type CellConcentration mouseorrat 1.5x106cellsperml hamster 0.5-1.0x106cellsperml